ResearcherSecond Affiliated Hospital of Nanchang UniversityActive in the last 2 years
Wenming Zhang
Matched on ORCID iD 0000-0002-9575-7713; OpenAlex author ID A5100761287. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 3
- The deubiquitylase OTUB1 drives gemcitabine resistance in pancreatic cancer by enhancing pyrimidine metabolism through modulating DHODH mRNA stability. Co-author DOI 10.1038/s41419-025-08001-4↗
- Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a nutrient-poor microenvironment. Co-author DOI 10.1038/s41419-024-07048-z↗
- SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. Co-author DOI 10.1038/s41388-023-02843-y↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Leifeng Chen · 3 shared papers, 2023–2025 · strength 0.62
- Paper The deubiquitylase OTUB1 drives gemcitabine resistance in pancreatic cancer by enhancing pyrimidine metabolism through … DOI 10.1038/s41419-025-08001-4↗
- Paper Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a n… DOI 10.1038/s41419-024-07048-z↗
- Paper SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. DOI 10.1038/s41388-023-02843-y↗
- Xiaogang Peng · 2 shared papers, 2024–2025 · strength 0.47
- Paper The deubiquitylase OTUB1 drives gemcitabine resistance in pancreatic cancer by enhancing pyrimidine metabolism through … DOI 10.1038/s41419-025-08001-4↗
- Paper Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a n… DOI 10.1038/s41419-024-07048-z↗
- Yunyan Du · 2 shared papers, 2023–2024 · strength 0.37
- Paper Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a n… DOI 10.1038/s41419-024-07048-z↗
- Paper SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. DOI 10.1038/s41388-023-02843-y↗
- Fan Zhou · 1 shared paper, 2024 · strength 0.22
- Ben Che · 1 shared paper, 2023 · strength 0.15
- Rongfa Yuan · 1 shared paper, 2023 · strength 0.15
- Xueqiang Deng · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.